check_circleStudy Completed

Tinea

Bayer Identifier:

Trial_0117

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Study to test the effectiveness and local tolerance of BAY H 4502 1% solution compared to placebo in subjects with tinea corporis and tinea inguinalis

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

21 - 57 Years
  • -

  • -

Trial summary

Enrollment Goal
40
Trial Dates
October 1979 - August 1980
Phase
Phase 2
Could I Receive a placebo
N/A
Products
Mycospor/Canesten Extra (Bifonazole, BAYH4502)
Accepts Healthy Volunteer
N/A

Trial design

Randomized, double blind, placebo controlled study to test the effectiveness and local tolerance of BAY H 4502 1% solution compared to placebo in subjects with tinea corporis and tinea inguinalis
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.